CRSP Key Financial Ratios - CRISPR Therapeutics AG

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	17.85	—	-17.02%	-25.83%
2026-03-31	17.96	—	-20.86%	-31.33%
2025-12-31	13.32	—	-25.67%	-30.26%
2025-09-30	16.22	—	-21.75%	-25.49%
2025-06-30	16.61	—	-23.05%	-27.34%
2025-03-31	15.64	—	-17.80%	-21.08%
2024-12-31	22.07	—	-16.34%	-18.96%
2024-09-30	21.64	—	-10.62%	-12.35%
2024-06-30	15.73	—	-11.36%	-13.42%
2024-03-31	17.81	—	-8.90%	-10.42%
2023-12-31	17.54	—	-6.89%	-8.16%
2023-09-30	15.83	—	-16.94%	-20.46%
2023-06-30	14	—	-18.93%	-22.90%
2023-03-31	13	—	-23.35%	-28.25%
2022-12-31	15.3	—	-28.99%	-34.67%
2022-09-30	12.81	—	-28.93%	-34.84%
2022-06-30	17.57	—	-25.71%	-30.30%
2022-03-31	19.88	—	11.96%	13.88%
2021-12-31	20.17	—	13.72%	15.74%
2021-09-30	26.18	—	14.60%	16.39%
2021-06-30	26.23	—	15.40%	17.15%
2021-03-31	22.05	—	-20.04%	-21.73%
2020-12-31	18.21	—	-19.08%	-20.96%
2020-09-30	16.53	—	-14.23%	-15.73%
2020-06-30	12.96	—	1.87%	2.15%
2020-03-31	16.87	—	4.52%	5.14%
2019-12-31	17.29	—	6.27%	7.12%
2019-09-30	8.32	—	-1.56%	-1.90%
2019-06-30	13.96	—	-40.55%	-54.51%
2019-03-31	15.84	—	-37.18%	-48.73%
2018-12-31	16.81	—	-33.74%	-42.07%
2018-09-30	15.39	—	-22.60%	-28.10%
2018-06-30	17.89	—	-25.84%	-34.41%
2018-03-31	24.42	—	-20.08%	-25.89%
2017-12-31	17.12	—	-25.19%	-36.39%
2017-09-30	21.34	—	-18.21%	-28.72%
2017-06-30	17.79	—	-13.57%	-20.92%
2017-03-31	17.53	—	-11.23%	-16.83%
2016-12-31	14.56	—	-6.72%	-9.95%
2016-09-30	2.97	—	-18.86%	84.10%
2015-12-31	15.44	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	13.32	—	-25.67%	-30.26%
2024-12-31	22.07	—	-16.34%	-18.96%
2023-12-31	17.54	—	-6.89%	-8.16%
2022-12-31	15.3	—	-28.99%	-34.67%
2021-12-31	20.17	—	13.72%	15.74%
2020-12-31	18.21	—	-19.08%	-20.96%
2019-12-31	17.29	—	6.27%	7.12%
2018-12-31	16.81	—	-33.74%	-42.07%
2017-12-31	17.12	—	-25.19%	-36.39%
2016-12-31	14.56	—	-6.72%	-9.95%
2015-12-31	15.44	—	-16.00%	87.65%
2014-12-31	—	—	—	100.50%